Suhas Palshikar

A crisis of political courage


Suhas Palshikar

Quick View

Ads by Google

Capita loses UK criminal records contract to TCS

British outsourcing firm Capita said on Wednesday it had lost out on a new government contract to run criminal records checks after the Home Office pursued talks with a rival supplier. The trade union representing staff under Capita's existing contract said the coalition government is likely to award the deal to Tata Consultancy Services, part of Tata Group. Analysts also expected TCS to get the nod. Capita has run the UK's Criminal Records Bureau disclosure service for over 10 years under a deal worth around £400 million ($650 million), and had hoped to secure a similar contract to support the replacement Disclosure and Barring Service (DBS).

Pfizer to appeal decision to revoke Sutent patent

Pfizer, the India unit of US drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug Sutent. The company, which will appeal before the Intellectual Property Appellate Board, said on Friday the Indian Patent Office's decision raised concerns over India's commitment to protect intellectual property.

"We believe the decision undermines intellectual property rights in India and we will vigorously defend our basic Sutent patent," Jazz Tobaccowalla, managing director of Pfizer India, said.

Parry Nutra to market its US arm's products

Parry Nutraceuticals, a division of EID Parry (I), has decided to market a host of wellness products of its US subsidiary, US Nutraceuticals, into the Indian market through 'Parry's Wellness' brand to tap the R10,000-crore nutraceuticals market in India, said Sajiv Menon, business head, Parry Nutraceuticals. Speaking to FE, he said: "We are marketing number of products, which are being developed in India, through 22,000 outlets across the country in the OTC format. We have decided to introduce some of the products of our US subsidiary (formerly Valensa) into India in the next three to six months."

... contd.

Ads by Google
Please read our terms of use before posting comments
TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
comments powered by Disqus